Literature DB >> 8564779

Characteristics of muscarinic cholinoceptors in airways of antigen-induced airway hyperresponsive rats.

Y Chiba1, M Misawa.   

Abstract

The antagonist and agonist binding sites of muscarinic receptors were investigated by using membrane preparations of airways from nonsensitized normal control, sensitized control and repeatedly antigen challenged rats. The in vitro bronchial responsiveness to ACh was markedly increased in repeatedly antigen challenged group but not in sensitized control group. No significant difference was observed in receptor density and antagonist affinity among these three groups. The affinity of ACh for high-affinity agonist binding sites of repeatedly antigen challenged group was much greater than those in the other groups; the affinity significantly reduced in the presence of GTP gamma S. We concluded that enhanced G protein level might be involved in inducing airway hyperresponsiveness in rats.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 8564779     DOI: 10.1016/0742-8413(95)00061-5

Source DB:  PubMed          Journal:  Comp Biochem Physiol C Pharmacol Toxicol Endocrinol        ISSN: 1367-8280


  10 in total

1.  Low-level laser therapy (LLLT) attenuates RhoA mRNA expression in the rat bronchi smooth muscle exposed to tumor necrosis factor-alpha.

Authors:  Flávia Mafra de Lima; Jan M Bjordal; Regiane Albertini; Fábio V Santos; Flavio Aimbire
Journal:  Lasers Med Sci       Date:  2010-09       Impact factor: 3.161

2.  Augmented acetylcholine-induced translocation of RhoA in bronchial smooth muscle from antigen-induced airway hyperresponsive rats.

Authors:  Y Chiba; H Sakai; M Misawa
Journal:  Br J Pharmacol       Date:  2001-07       Impact factor: 8.739

3.  Augmented acetylcholine-induced, Rho-mediated Ca2+ sensitization of bronchial smooth muscle contraction in antigen-induced airway hyperresponsive rats.

Authors:  Y Chiba; Y Takada; S Miyamoto; M MitsuiSaito; H Karaki; M Misawa
Journal:  Br J Pharmacol       Date:  1999-06       Impact factor: 8.739

4.  Role of parasympathetic nerves and muscarinic receptors in allergy and asthma.

Authors:  Gregory D Scott; Allison D Fryer
Journal:  Chem Immunol Allergy       Date:  2012-06-26

5.  Effect of low level laser therapy on bronchial hyper-responsiveness.

Authors:  Flávio Aimbire; Flávia Mafra de Lima; Maricilia S Costa; Regiane Albertini; João Carlos Correa; Vegard V Iversen; Jan M Bjordal
Journal:  Lasers Med Sci       Date:  2008-11-12       Impact factor: 3.161

6.  Involvement of RhoA-mediated Ca2+ sensitization in antigen-induced bronchial smooth muscle hyperresponsiveness in mice.

Authors:  Yoshihiko Chiba; Ayako Ueno; Koji Shinozaki; Hisao Takeyama; Shuji Nakazawa; Hiroyasu Sakai; Miwa Misawa
Journal:  Respir Res       Date:  2005-01-08

Review 7.  Mechanisms underlying the pathogenesis of hyper-contractility of bronchial smooth muscle in allergic asthma.

Authors:  Hiroyasu Sakai; Wataru Suto; Yuki Kai; Yoshihiko Chiba
Journal:  J Smooth Muscle Res       Date:  2017

8.  Imaging mass spectrometry to visualise increased acetylcholine in lungs of asthma model mice.

Authors:  Takeshi Matsuda; Yuzo Suzuki; Tomoyuki Fujisawa; Yasunori Suga; Nobuyuki Saito; Takafumi Suda; Ikuko Yao
Journal:  Anal Bioanal Chem       Date:  2020-05-04       Impact factor: 4.142

9.  Human lung tissue provides highly relevant data about efficacy of new anti-asthmatic drugs.

Authors:  Olga Danov; Sharon Melissa Jiménez Delgado; Helena Obernolte; Sophie Seehase; Susann Dehmel; Peter Braubach; Hans-Gerd Fieguth; Gabriele Matschiner; Mary Fitzgerald; Danny Jonigk; Sascha Knauf; Olaf Pfennig; Gregor Warnecke; Judy Wichmann; Armin Braun; Katherina Sewald
Journal:  PLoS One       Date:  2018-11-30       Impact factor: 3.240

10.  Implications of immune-inflammatory responses in smooth muscle dysfunction and disease.

Authors:  Fumitake Usui-Kawanishi; Masafumi Takahashi; Hiroyasu Sakai; Wataru Suto; Yuki Kai; Yoshihiko Chiba; Keizo Hiraishi; Lin Hai Kurahara; Masatoshi Hori; Ryuji Inoue
Journal:  J Smooth Muscle Res       Date:  2019
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.